Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.

By S. Jang, O. Y. Kim, C. Yoon, Dong-Sic Choi, Tae-Young Roh, Jaesung Park, J. Nilsson, Jan Lötvall, Yoon-Keun Kim, Y. Gho. ACS Nano, 2013

934 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/b333a08bf3e643e80a706c5c5caebf685cdb056c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

In Molecular Biology

Citations in the corpus

Using exosomes, naturally-equipped nanocarriers, for drug delivery (2015, methodology): “In another study, the breakdown of parental cells (monocytes/macrophages) loaded with anticancer agents, Dox, Gentamicin, 5-Fluorouracil, or Carboplatin with subsequent isolation of exosome-like nanoparticles was also suggested [91].”
Exosomes as Drug Delivery Vehicles for Parkinson’s Disease Therapy (2015, methodology): “Noteworthy, the effects of Dox-loaded exosomes were superior than the commercially available Dox-loaded liposomes, Doxil; the liposomal formulation was inefficient in reducing tumor growth in this model [41].”
Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. (2015, background): “In addition to the therapeutic transfer of interfering RNAs, chemotherapeutics such as doxorubicin have been loaded onto exosomes and used to inhibit growth of breast and colon cancers (106, 107).”
Exosome Theranostics: Biology and Translational Medicine (2018, background): “a breaking down cells via serial extrusion through filters with diminishing pore sizes (Figure 4) [186].”
EVpedia: a community web portal for extracellular vesicles research (2015, background): “Publications on EVs have grown rapidly during the last several years, indicating that the field of EVs is expanding intensively (Fig.”
Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio (2015, methodology): “3 exosome was similar to previous reports where doxorubicin was encapsulated in exosomes released by human umbilical vein endothelial cells (8).”